These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 21726256)
1. Use of tacrolimus in the treatment of autoimmune hepatitis: a single centre experience. Tannous MM; Cheng J; Muniyappa K; Farooq I; Bharara A; Kappus M; Luketic V; Stravtiz RT; Fuchs M; Puri P; Sanyal A; Sterling R Aliment Pharmacol Ther; 2011 Aug; 34(3):405-7. PubMed ID: 21726256 [No Abstract] [Full Text] [Related]
2. The use of tacrolimus in refractory autoimmune hepatitis in children and adults: a single center experience. Al Taii H; Hanouneh MA; Hanouneh I; Lopez R; Zein N; Alkhouri N Scand J Gastroenterol; 2017 Feb; 52(2):157-158. PubMed ID: 27633047 [No Abstract] [Full Text] [Related]
3. Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus. Chatur N; Ramji A; Bain VG; Ma MM; Marotta PJ; Ghent CN; Lilly LB; Heathcote EJ; Deschenes M; Lee SS; Steinbrecher UP; Yoshida EM Liver Int; 2005 Aug; 25(4):723-7. PubMed ID: 15998421 [TBL] [Abstract][Full Text] [Related]
4. Autoimmune hepatitis: a fertile field. Lake JR Gut; 2001 Jan; 48(1):7-8. PubMed ID: 11115813 [No Abstract] [Full Text] [Related]
5. Autoimmune hepatitis: are we using the right therapy? Murray KF J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):18-9. PubMed ID: 17204947 [No Abstract] [Full Text] [Related]
14. Role of mycophenolate mofetil in the treatment of autoimmune hepatitis. Schramm C; Lohse AW J Hepatol; 2011 Sep; 55(3):510-511. PubMed ID: 21281682 [No Abstract] [Full Text] [Related]